Skin and Soft Tissue Complications in Pediatric Leukemia Patients With and Without Central Venous Catheters

We aimed to retrospectively evaluate the skin and soft tissue complications secondary to procedures in acute leukemia patients with and without catheters. Eighty-seven acute leukemia patients (75 acute lymphoblastic leukemia, 12 acute myeloid leukemia ) were included. There were 30 patients with 37 catheter use (6 port, 31 Hickman catheter) and 57 patients without catheter. In patients with catheters, skin and soft tissue complications were seen in 20 (66%) children. The most frequent complication was cellulitis (55%). In the patients without catheter, skin and soft tissue complications were seen in 37 (65%) patients. Cellulitis (37.8%) and extravasation (37.8%) were the most frequent causes. When the frequency of skin and soft tissue complications in patients with and without catheters were compared with each other, there was statistically no significant difference (P=0.792). The duration of chemotherapy was significantly longer in patients who developed skin and soft tissue complications with or without catheters when compared with the duration of the therapy in patients without any skin and soft tissue complications (259.2±36.3 and 218.3±58.3 d, respectively; P<0.0001). In pediatric leukemia patients, with or without catheters, skin and soft tissue complications are common and these complications may prolong the duration of chemotherapy.

[1]  B. de Camargo,et al.  A Proposed Score for Predicting Severe Infection Complications in Children With Chemotherapy-induced Febrile Neutropenia , 2006, Journal of pediatric hematology/oncology.

[2]  Z. Samra,et al.  Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. , 2006, The Journal of hospital infection.

[3]  M. Tugay,et al.  TOTALLY IMPLANTABLE CENTRAL VENOUS ACCESS DEVICES IN CHILDREN WITH HEMATO-ONCOLOGIC MALIGNANCIES: Evaluation of Complications and Comparison of Incidence of Febrile Episodes with Similar Patients Without Central Venous Access Devices , 2006, Pediatric hematology and oncology.

[4]  D. Nadal,et al.  Port-A-Cath infections in children with cancer. , 2004, European journal of cancer.

[5]  Chris L. Fryer,et al.  Factors influencing central line infections in children with acute lymphoblastic leukemia: Results of a single institutional study , 2004, Pediatric blood & cancer.

[6]  C. Male,et al.  Central venous line-related thrombosis in children: association with central venous line location and insertion technique. , 2003, Blood.

[7]  B. Lange,et al.  Evolving concepts of management of febrile neutropenia in children with cancer. , 2002, Medical and pediatric oncology.

[8]  F. Wesenberg,et al.  Prevalence of thrombophilia and central venous catheter-associated neck vein thrombosis in 41 children with cancer--a prospective study. , 2002, Medical and pediatric oncology.

[9]  D. Maki,et al.  The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  L. Mermel,et al.  Guidelines for the management of intravascular catheter-related infections. , 2001, Infection control and hospital epidemiology.

[11]  L. Mermel,et al.  Guidelines for the Management of Intravascular Catheter-Related Infections , 2001, Infection Control &#x0026; Hospital Epidemiology.

[12]  N. Rollins,et al.  Catheter-related thrombosis in children with cancer. , 2001, The Journal of pediatrics.

[13]  A. Thomas,et al.  Totally implantable central venous access devices for paediatric oncology patients. , 1999, Medical and pediatric oncology.

[14]  H. Sather,et al.  Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 1999, Journal of pediatric hematology/oncology.

[15]  M. Ertem,et al.  Right atrial catheter-related complications in pediatric oncology patients: the situation in a developing country. , 1999, Pediatric hematology and oncology.

[16]  P. Monagle,et al.  Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. , 1998, The Journal of pediatrics.

[17]  D. Shaul,et al.  Risk factors for early infection of central venous catheters in pediatric patients. , 1998, Journal of the American College of Surgeons.

[18]  L. Pagano,et al.  Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators. , 1997, Haematologica.

[19]  M. Manco‐Johnson,et al.  Diagnosis and Treatment of Venous Thromboembolism in Children and Adolescents , 1995, Thrombosis and Haemostasis.

[20]  J. Lilleyman,et al.  Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia , 1994, The Lancet.

[21]  M. Bernstein,et al.  Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. , 1994, Blood.

[22]  P. Colombani,et al.  Atypical thrombotic and septic complications of totally implantable venous access devices in patients with cystic fibrosis , 1992, Pediatric pulmonology.

[23]  Mark L. Greenberg,et al.  Complications of Indwelling Venous Access Lines in the Pediatric Hematology Patient: A Prospective Comparison of External Venous Catheters and Subcutaneous Ports , 1991, The American journal of pediatric hematology/oncology.

[24]  R. Barr,et al.  Right Atrial Catheters in Children with Cancer: A Decade of Experience in the Use of Tunnelled, Exteriorized Devices at a Single Institution , 1991, The American journal of pediatric hematology/oncology.

[25]  A. Berg,et al.  The effect of right atrial catheters on infectious complications of chemotherapy in children. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  D. Fairclough,et al.  A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. , 1990, Journal of pediatric surgery.

[27]  M. Rafferty,et al.  A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  L. Rubin,et al.  Infection rates of Broviac-Hickman catheters and implantable venous devices. , 1988, American journal of diseases of children.

[29]  S. Piomelli,et al.  Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of venous access lines. , 1984, The American journal of pediatric hematology/oncology.